For the 6th consecutive year SwedenBIO hosts its Life Science Investment Day Scandinavia. This annual event has been highly appreciated, providing an efficient meeting and networking platform for investors interested in meeting the Scandinavian life science community. Here companies, investors and decision makers connect and explore potential collaborations. The Scandinavian region is well known for its strong life science sector with innovative and leading global companies.
Life Science Investment Day Scandinavia 2011 will have presentations from 30 companies in 3 parallel sessions with focus on Drug Discovery & Therapeutics, Medtech and Enabling Technologies & Diagnostics, respectively. In addition, the Main Stage stage will have an International Session with international partners from USA, China and India.
Main Sponsor 2011: Amgen
SwedenBIO has conducted a benchmarking of the Life Science industry in Sweden.
In conclusion, Sweden has a strong innovation power with conditions suitable for knowledge-intensive industry sectors such as the Life Science industry, however there are a number of indicators and structural changes that need to be considered to be able to keep Sweden's Life Science industry from declining.